Siemens Healthcare launched the ACUSON S3000*, its latest ultra-premium ultrasound platform, at the 97th Scientific Assembly and Annual Meeting of the Radiological Society of North America (RSNA) in Chicago, USA. The new system includes advanced automated ultrasound fusion imaging** as well as multi-modality review capabilities** to provide additional clinical and spatial information in the analysis of complex pathology and/or when performing interventional procedures such as biopsies.
The ACUSON S3000*, Siemens’ latest ultra-premium ultrasound platform offers best-in-class image quality and ultrasound imaging capabilities, including advanced ultrasound fusion imaging* and multi-modality review*. Additionally, it features the most comprehensive suite of elastography applications in the industry. The system’s performance is supported by the new high-density (HD) 8C3 HD transducer*, specially designed for obstetrics and pediatric applications. * Works in Progress. Not commercially available.
In combination with their comprehensive suite of elastography applications, Siemens highlighted its new strain imaging application Virtual Touch tissue IQ** imaging, reinforcing the company’s role as a leader in strain elastography imaging. Also at RSNA 2011, Siemens introduced the latest addition to their family of high-density (HD) transducers: the 8C3 HD transducer* specially designed for obstetrics and pediatric applications.
The new ultra-premium ACUSON S3000 ultrasound system advances Siemens' pioneering ultrasound technologies with its proprietary eSie Fusion** imaging, which enables the automatic fusion of 3-D computed tomography (CT) volumes with real-time ultrasound via a single click. Current fusion techniques require time-consuming manual registration of CT or magnetic resonance (MR) images. They also require the patient to lie motionless throughout the entire exam to avoid elaborate manual realignments. The automatic, one-click advanced registration capabilities of the ACUSON S3000 system eliminate these limitations, reducing CT image registration to mere seconds, and profoundly simplifying manual registration techniques to enhance workflow during MR volume registration.
"Using the new eSie Fusion** imaging technology allows us to significantly speed up our workflow", said assistant professor Dr. Dirk-André Clevert, section chief of the Interdisciplinary Ultrasound Center at Munich University Hospital Grosshadern, Germany, and one of the first physicians to test eSie Fusion. "Previously, the success of interventions was generally monitored by follow-up CT examinations. However, due to the new ultrasound fusion solution it should be possible to reduce the number of follow-ups done with CT. The use of fusion provides us with improved clinical information – without additional radiation. This is a great advantage for both the patients and the healthcare provider." Fusion imaging can play an important role not only in diagnosis and follow-up, but also in image-guided interventions.
Increased Diagnostic Confidence Through Multi-Modality Review
In addition to fusion imaging, the ACUSON S3000* system features multi-modality review capabilities allowing CT and/or MR images to be imported into the ultrasound system for a rapid, easy side-by-side comparison. These capabilities provide an additional layer of information to further increase diagnostic confidence and confirm therapeutic decisions.
Stiffness Map and Quantification in One Image
Building on its vast experience in ultrasound elastography imaging, Siemens showcased the most comprehensive suite of elastography applications available in the industry. The latest application to confirm Siemens' leadership in this field is Virtual Touch tissue IQ**, which permits the simultaneous display of a color-coded tissue stiffness map and shear wave velocity measurements in one single image. This application allows immediate visual assessment of lesions and their stiffness characteristics, while at the same time providing simultaneous quantitative evaluation.
Since its introduction in 2005, manual-compression eSie Touch elasticity imaging has been complemented by push-pulse Virtual Touch tissue software applications***, Siemens' proprietary implementation of ARFI (Acoustic Radiation Force Impulse) imaging. Virtual Touch tissue imaging*** and eSie Touch elasticity imaging create a visual stiffness map (known as an elastogram) via tissue compression. Complementing these two technologies, Virtual Touch tissue quantification*** additionally measures the propagation speed of shear waves to offer the first and only quantitative assessment of increased tissue stiffness – a frequent sign of pathology.
HD Transducer Technology – More Accurate Information in Every Clinical Image
Siemens' most recent proprietary high-density (HD) ultrasound transducer technology ensures the best possible information for the creation of every clinical image. Unlike conventional ultrasound transducer technologies, HD technology employs high-density ultrasound elements that deliver greater signal fidelity improving image compounding and providing the basis for noise- and clutter-free images with a high degree of contrast resolution and clear tissue differentiation.
Siemens' new 8C3 HD* ultrasound probe was primarily designed for obstetric and pediatric applications, permitting high-resolution imaging in a wide range of exams. The transducer features a small footprint for improved surface contact and enhanced scanning performance. A 50 percent larger field-of-view enables the display of a full third-trimester fetal head, improving measurements and anatomic visualization. The range of ultrasound transducers enabled on the ACUSON S3000* system also includes the recently introduced 6C1 HD high-density ultrasound probe for radiology, gynecology and obstetrics, as well as the 18L6 HD probe for superb imaging in small parts, including the breast and thyroid.
Preparing for a Changing Healthcare Market
To further strengthen its innovative power and competitiveness, Siemens Healthcare recently launched Agenda 2013, a global initiative to prepare for the changing healthcare market. It defines four fields of action – innovation, competitiveness, regional footprint, and people development – with specific measures to be implemented over the next two years. As part of this new initiative, the Siemens Ultrasound Business Unit will further extend its innovative portfolio with products that demonstrate how ultrasound solutions help manage the cost pressures in healthcare without sacrificing excellence in patient care.
* 510 (k) pending. Not commercially available.
** Works in Progress.
*** Virtual Touch tissue imaging and Virtual Touch tissue quantification are not available in the United States.The Siemens Healthcare Sector is one of the world's largest suppliers to the healthcare industry and a trendsetter in medical imaging, laboratory diagnostics, medical information technology and hearing aids. Siemens offers its customers products and solutions for the entire range of patient care from a single source – from prevention and early detection to diagnosis, and on to treatment and aftercare. By optimizing clinical workflows for the most common diseases, Siemens also makes healthcare faster, better and more cost-effective. Siemens Healthcare employs some 51,000 employees worldwide and operates around the world. In fiscal year 2011 (to September 30), the Sector posted revenue of 12.5 billion euros and profit of around 1.3 billion euros.
The statements by Siemens' customers described herein are on results that were achieved in the customer's unique setting. Since there is no "typical" hospital and many variables exist, e.g., hospital size, case mix, level of IT adoption, there can be no guarantee that others will achieve the same results.
Reference Number: HCP201111012eContact
Marion Bludszuweit | Siemens Healthcare
High-resolution 3D view inside breast tumors with opto-acoustic mesoscopy
26.05.2020 | Technische Universität München
New double-contrast technique picks up small tumors on MRI
26.05.2020 | University of California - Davis
Early detection of tumors is extremely important in treating cancer. A new technique developed by researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from normal tissue. The work is published May 25 in the journal Nature Nanotechnology.
researchers at the University of California, Davis offers a significant advance in using magnetic resonance imaging to pick out even very small tumors from...
Microelectronics as a key technology enables numerous innovations in the field of intelligent medical technology. The Fraunhofer Institute for Biomedical Engineering IBMT coordinates the BMBF cooperative project "I-call" realizing the first electronic system for ultrasound-based, safe and interference-resistant data transmission between implants in the human body.
When microelectronic systems are used for medical applications, they have to meet high requirements in terms of biocompatibility, reliability, energy...
Thomas Heine, Professor of Theoretical Chemistry at TU Dresden, together with his team, first predicted a topological 2D polymer in 2019. Only one year later, an international team led by Italian researchers was able to synthesize these materials and experimentally prove their topological properties. For the renowned journal Nature Materials, this was the occasion to invite Thomas Heine to a News and Views article, which was published this week. Under the title "Making 2D Topological Polymers a reality" Prof. Heine describes how his theory became a reality.
Ultrathin materials are extremely interesting as building blocks for next generation nano electronic devices, as it is much easier to make circuits and other...
Scientists took a leukocyte as the blueprint and developed a microrobot that has the size, shape and moving capabilities of a white blood cell. Simulating a blood vessel in a laboratory setting, they succeeded in magnetically navigating the ball-shaped microroller through this dynamic and dense environment. The drug-delivery vehicle withstood the simulated blood flow, pushing the developments in targeted drug delivery a step further: inside the body, there is no better access route to all tissues and organs than the circulatory system. A robot that could actually travel through this finely woven web would revolutionize the minimally-invasive treatment of illnesses.
A team of scientists from the Max Planck Institute for Intelligent Systems (MPI-IS) in Stuttgart invented a tiny microrobot that resembles a white blood cell...
By studying the chemical elements on Mars today -- including carbon and oxygen -- scientists can work backwards to piece together the history of a planet that once had the conditions necessary to support life.
Weaving this story, element by element, from roughly 140 million miles (225 million kilometers) away is a painstaking process. But scientists aren't the type...
19.05.2020 | Event News
07.04.2020 | Event News
06.04.2020 | Event News
26.05.2020 | Physics and Astronomy
26.05.2020 | Life Sciences
26.05.2020 | Information Technology